Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
7.55
-0.07 (-0.92%)
Oct 24, 2025, 4:00 PM EDT - Market closed
Aclarion Revenue
Aclarion had revenue of $19.32K in the quarter ending June 30, 2025, with 76.09% growth. This brings the company's revenue in the last twelve months to $62.95K, up 16.68% year-over-year. In the year 2024, Aclarion had annual revenue of $45.72K, down -39.36%.
Revenue (ttm)
$62.95K
Revenue Growth
+16.68%
P/S Ratio
69.85
Revenue / Employee
$10,491
Employees
6
Market Cap
4.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 45.72K | -29.68K | -39.36% |
| Dec 31, 2023 | 75.40K | 14.96K | 24.75% |
| Dec 31, 2022 | 60.44K | 152.00 | 0.25% |
| Dec 31, 2021 | 60.29K | 11.64K | 23.93% |
| Dec 31, 2020 | 48.65K | 21.76K | 80.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ACON News
- 3 days ago - Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH - GlobeNewsWire
- 16 days ago - Aclarion to Present at the LD Micro Main Event XIX - Newsfile Corp
- 4 months ago - Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum - GlobeNewsWire
- 5 months ago - Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site - GlobeNewsWire
- 5 months ago - Aclarion Announces Texas Back Institute as New CLARITY Trial Site - GlobeNewsWire
- 6 months ago - Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - GlobeNewsWire
- 6 months ago - Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - GlobeNewsWire
- 6 months ago - Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis - GlobeNewsWire